| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6242093 | Respiratory Medicine | 2011 | 8 Pages |
Abstract
Decisions on whether or not inhaled corticosteroids can be safely withdrawn in mild-to-moderate COPD can be facilitated by assessment of sputum inflammation, particularly eosinophil numbers, next to packyears smoking, season, and duration of COPD symptoms.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Jeroen J.W. Liesker, Erik Bathoorn, Dirkje S. Postma, Judith M. Vonk, Wim Timens, Huib A.M. Kerstjens,